Source:http://linkedlifedata.com/resource/pubmed/id/19330330
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
11
|
| pubmed:dateCreated |
2009-8-19
|
| pubmed:abstractText |
Alloreaction is known to accumulate several theoretical advantages that can improve dendritic cell (DC)-based anti-infective or antitumour strategies. Allogeneic DC have already been tested in experimental and clinical studies, but their efficacy compared with their autologous counterparts was rarely investigated and conclusions diverge.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
1432-0851
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
58
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1831-41
|
| pubmed:meshHeading |
pubmed-meshheading:19330330-Antigen-Presenting Cells,
pubmed-meshheading:19330330-Antigens, Neoplasm,
pubmed-meshheading:19330330-Cells, Cultured,
pubmed-meshheading:19330330-Cytokines,
pubmed-meshheading:19330330-Dendritic Cells,
pubmed-meshheading:19330330-HLA-A2 Antigen,
pubmed-meshheading:19330330-Humans,
pubmed-meshheading:19330330-T-Lymphocytes,
pubmed-meshheading:19330330-T-Lymphocytes, Cytotoxic
|
| pubmed:year |
2009
|
| pubmed:articleTitle |
Selected allogeneic dendritic cells markedly enhance human tumour antigen-specific T cell response in vitro.
|
| pubmed:affiliation |
Institut Jean Godinot, Unité de Thérapie Cellulaire, Reims, France. alban.gervais@reims.fnclcc.fr
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|